drugset / Trial / NCT02063035

Effectiveness Study of the Drug Tranexamic Acid to Reduce Post-surgery Blood Loss in Spinal Surgery

NCT02063035 ↗

Phase 4 Completed 29 enrolled Massachusetts General Hospital
RandomizedParallel-groupTriple-blindSupportive care

Summary

Hypothesis: Topical application of Tranexamic acid into the surgical wound during spine surgery will decrease the overall blood loss post-operatively. This reduction in blood loss will reduce the need for transfusion. In addition it will also significantly reduce the cost of the surgical procedure. Specific Aim 1: The goal of this study is to quantitatively assess whether topical application of tranexamic acid placed into the surgical wound during lumbar spine surgery will decrease post-operative blood loss, thus lowering the need for blood transfusions. By reducing the number of transfusions participants can avoid the well-known complications associated with them. The investigators do not plan on measuring serum tranexamic acid levels. Several meta-analyses and level I studies have shown that intravenous (IV) administration of tranexamic acid is effective in reducing postoperative blood loss and the need for transfusion.

Timeline

Start
2012-08
Primary completion
2015-04-22
Completion
2015-04-22

Outcome

Missed primary endpoint

registry analysis (superiority test); Tranexamic Acid vs Placebo; p = 0.1318; Wilcoxon (Mann-Whitney) NCT02063035 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 3 g Topical